Physician Perspectives on Reducing Curative Cancer Treatment Intensity for Populations Underrepresented in Clinical Trials.

Gabrielle B RocqueCourtney AndrewsValerie M LawhonStacey A IngramRachel M FrazierMary Lou SmithLynne I WagnerLisa ZubkoffLauren P WallnerAntonio C Wolff

Published in: The oncologist (2022)

NCT03248258.

Keyphrases

clinical trial
primary care
emergency department
high intensity
rectal cancer
phase ii
prognostic factors
genetic diversity
open label
phase iii
study protocol